|
ZNF227 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.51100251702496E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.54600007743022E-10 |
| Normal-vs-Stage2 |
5.0563000453252E-09 |
| Normal-vs-Stage3 |
3.41515704604944E-12 |
| Normal-vs-Stage4 |
3.17557091733534E-12 |
| Stage1-vs-Stage2 |
8.900000E-01 |
| Stage1-vs-Stage3 |
2.432300E-02 |
| Stage1-vs-Stage4 |
1.451520E-02 |
| Stage2-vs-Stage3 |
1.495630E-01 |
| Stage2-vs-Stage4 |
8.872200E-02 |
| Stage3-vs-Stage4 |
7.647600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.39870337534376E-11 |
| Normal-vs-AfricanAmerican |
2.9599999999963E-06 |
| Normal-vs-Asian |
4.67199999798495E-08 |
| Caucasian-vs-AfricanAmerican |
7.239000E-01 |
| Caucasian-vs-Asian |
1.513640E-01 |
| AfricanAmerican-vs-Asian |
5.133800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.55440019031528E-10 |
| Normal-vs-Female |
1.26130217381615E-11 |
| Male-vs-Female |
2.579000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.39850020453025E-10 |
| Normal-vs-Age(41-60Yrs) |
7.60570495472734E-11 |
| Normal-vs-Age(61-80Yrs) |
3.07642800123631E-12 |
| Normal-vs-Age(81-100Yrs) |
2.276500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.320000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.358630E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.831800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.955440E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.395200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.594000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.757170E-04 |
| Classical-VS-Follicular |
2.287200E-01 |
| Classical-VS-Other |
9.531200E-01 |
| Classical-VS-Normal |
1.03950004159969E-09 |
| Tall-VS-Follicular |
1.421860E-02 |
| Tall-VS-Other |
3.103000E-01 |
| Tall-VS-Normal |
1.86406445834564E-12 |
| Follicular-VS-Other |
7.638800E-01 |
| Follicular-VS-Normal |
3.63959973270767E-10 |
| Other-VS-Normal |
1.014140E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.56039675309239E-11 |
| Normal-vs-N1 |
9.06652530829888E-12 |
| N0-vs-N1 |
9.052100E-02 |
|
|
